153 related articles for article (PubMed ID: 23413156)
41. Planning future clinical trials in Machado Joseph disease: Lessons from a phase 2 trial.
Saute JA; Rieder CR; Castilhos RM; Monte TL; Schumacher-Schuh AF; Donis KC; D'Ávila R; Souza GN; Russo AD; Furtado GV; Gheno TC; Souza DO; Saraiva-Pereira ML; Portela LV; Camey S; Torman VB; Jardim LB
J Neurol Sci; 2015 Nov; 358(1-2):72-6. PubMed ID: 26297649
[TBL] [Abstract][Full Text] [Related]
42. Six cases of SCA3/MJD patients that mimic hereditary spastic paraplegia in clinic.
Wang YG; Du J; Wang JL; Chen J; Chen C; Luo YY; Xiao ZQ; Jiang H; Yan XX; Xia K; Pan Q; Tang BS; Shen L
J Neurol Sci; 2009 Oct; 285(1-2):121-4. PubMed ID: 19608203
[TBL] [Abstract][Full Text] [Related]
43. [Diffusion weighted imaging of SCA3/MJD and SPG4].
Xing W; Wang X; Liao X; Shen L; Liao W
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2014 Aug; 39(8):825-30. PubMed ID: 25202952
[TBL] [Abstract][Full Text] [Related]
44. Clinical Scales Predict Significant Videofluoroscopic Dysphagia in Machado Joseph Disease Patients.
Russo AD; Reckziegel ER; Krum-Santos AC; Augustin MC; Scheeren B; Freitas CD; Torman VL; Saraiva-Pereira ML; Saute JA; Jardim LB
Mov Disord Clin Pract; 2015 Sep; 2(3):260-266. PubMed ID: 30363545
[TBL] [Abstract][Full Text] [Related]
45. Nonmotor Symptoms in Patients with Spinocerebellar Ataxia Type 10.
Moro A; Munhoz RP; Moscovich M; Arruda WO; Raskin S; Silveira-Moriyama L; Ashizawa T; Teive HAG
Cerebellum; 2017 Dec; 16(5-6):938-944. PubMed ID: 28589261
[TBL] [Abstract][Full Text] [Related]
46. Cancer in Machado-Joseph disease patients-low frequency as a cause of death.
Souza GN; Kersting N; Gonçalves TA; Pacheco DLO; Saraiva-Pereira ML; Camey SA; Saute JAM; Jardim LB
Cancer Genet; 2017 Apr; 212-213():19-23. PubMed ID: 28449807
[TBL] [Abstract][Full Text] [Related]
47. Spinocerebellar ataxia types 1, 2, 3, and 6: disease severity and nonataxia symptoms.
Schmitz-Hübsch T; Coudert M; Bauer P; Giunti P; Globas C; Baliko L; Filla A; Mariotti C; Rakowicz M; Charles P; Ribai P; Szymanski S; Infante J; van de Warrenburg BP; Dürr A; Timmann D; Boesch S; Fancellu R; Rola R; Depondt C; Schöls L; Zdienicka E; Kang JS; Döhlinger S; Kremer B; Stephenson DA; Melegh B; Pandolfo M; di Donato S; du Montcel ST; Klockgether T
Neurology; 2008 Sep; 71(13):982-9. PubMed ID: 18685131
[TBL] [Abstract][Full Text] [Related]
48. Cerebellar cognitive affective syndrome in Machado Joseph disease: core clinical features.
Braga-Neto P; Pedroso JL; Alessi H; Dutra LA; Felício AC; Minett T; Weisman P; Santos-Galduroz RF; Bertolucci PH; Gabbai AA; Barsottini OG
Cerebellum; 2012 Jun; 11(2):549-56. PubMed ID: 21975858
[TBL] [Abstract][Full Text] [Related]
49. Chronic pain in Machado-Joseph disease: a frequent and disabling symptom.
França MC; D'Abreu A; Friedman JH; Nucci A; Lopes-Cendes I
Arch Neurol; 2007 Dec; 64(12):1767-70. PubMed ID: 18071041
[TBL] [Abstract][Full Text] [Related]
50. Mutation detection in Machado-Joseph disease using repeat expansion detection.
Lindblad K; Lunkes A; Maciel P; Stevanin G; Zander C; Klockgether T; Ratzlaff T; Brice A; Rouleau GA; Hudson T; Auburger G; Schalling M
Mol Med; 1996 Jan; 2(1):77-85. PubMed ID: 8900536
[TBL] [Abstract][Full Text] [Related]
51. Association Between Body Mass Index and Disease Severity in Chinese Spinocerebellar Ataxia Type 3 Patients.
Yang JS; Chen PP; Lin MT; Qian MZ; Lin HX; Chen XP; Shang XJ; Wang DN; Chen YC; Jiang B; Chen YJ; Wang N; Chen WJ; Gan SR
Cerebellum; 2018 Aug; 17(4):494-498. PubMed ID: 29476441
[TBL] [Abstract][Full Text] [Related]
52. Detection of the Machado-Joseph disease/spinocerebellar ataxia three trinucleotide repeat expansion in families with autosomal dominant motor disorders, including the Drew family of Walworth.
Giunti P; Sweeney MG; Harding AE
Brain; 1995 Oct; 118 ( Pt 5)():1077-85. PubMed ID: 7496771
[TBL] [Abstract][Full Text] [Related]
53. Brain stem and cerebellum volumetric analysis of Machado Joseph disease patients.
Camargos ST; Marques W; Santos AC
Arq Neuropsiquiatr; 2011; 69(2B):292-6. PubMed ID: 21625753
[TBL] [Abstract][Full Text] [Related]
54. Genetic risk factors for modulation of age at onset in Machado-Joseph disease/spinocerebellar ataxia type 3: a systematic review and meta-analysis.
de Mattos EP; Kolbe Musskopf M; Bielefeldt Leotti V; Saraiva-Pereira ML; Jardim LB
J Neurol Neurosurg Psychiatry; 2019 Feb; 90(2):203-210. PubMed ID: 30337442
[TBL] [Abstract][Full Text] [Related]
55. Impaired P50 sensory gating in Machado-Joseph disease.
Ghisolfi ES; Maegawa GH; Becker J; Zanardo AP; Strimitzer IM; Prokopiuk AS; Pereira ML; Carvalho T; Jardim LB; Lara DR
Clin Neurophysiol; 2004 Oct; 115(10):2231-5. PubMed ID: 15351363
[TBL] [Abstract][Full Text] [Related]
56. Early vestibular dysfunction in Machado-Joseph disease detected by caloric test.
Yoshizawa T; Nakamagoe K; Ueno T; Furusho K; Shoji S
J Neurol Sci; 2004 Jun; 221(1-2):109-11. PubMed ID: 15178224
[TBL] [Abstract][Full Text] [Related]
57. Dominantly inherited ataxias: lessons learned from Machado-Joseph disease/spinocerebellar ataxia type 3.
Paulson HL
Semin Neurol; 2007 Apr; 27(2):133-42. PubMed ID: 17390258
[TBL] [Abstract][Full Text] [Related]
58. Parasympathetic autonomic dysfunction is more often evidenced than sympathetic autonomic dysfunction in fluctuating and polymorphic symptoms of "long-COVID" patients.
Zanin A; Amah G; Chakroun S; Testard P; Faucher A; Le TYV; Slama D; Le Baut V; Lozeron P; Salmon D; Kubis N
Sci Rep; 2023 May; 13(1):8251. PubMed ID: 37217645
[TBL] [Abstract][Full Text] [Related]
59. Body weight and dysautonomia in early Parkinson's disease.
Umehara T; Nakahara A; Matsuno H; Toyoda C; Oka H
Acta Neurol Scand; 2017 May; 135(5):560-567. PubMed ID: 27357472
[TBL] [Abstract][Full Text] [Related]
60. Altered heart rate control in response to postural change in patients with Machado-Joseph disease (SCA3).
Koyama Y; Asahina M; Honma K; Arai K; Hattori T
Cerebellum; 2009 Jun; 8(2):130-6. PubMed ID: 19009326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
